Author:
van Oostveen D. C.,Pieters R.,Peters G. J.,Veerman A. J. P.
Reference16 articles.
1. R. Pieters, D.R. Huismans, A.H. Loonen, G.J. Peters, K. Hählen, A. van der Does-van den Berg, E.R. van Wering, A.J.P. Veerman. Adenosine deaminase and purine nucleoside Phosphorylase in childhood lymphoblastic leukemia: Relation with differentiation stage, in vitro drug resistance and clinical prognosis. Leukemia 6: 375 (1992).
2. R. Pieters, D.R. Huismans, A.H. Loonen, G.J. Peters, K. Hählen, A. van der Does-van den Berg, E.R. van Wering, A.J.P. Veerman. Hypoxantine-guanine phosphoribosyltransferase in childhood leukemia: relation with immunophenotype, in vitro drug resistance and clinical prognosis. Int J Cancer 51: 213 (1992).
3. A.J.P. Veerman, P.H.G. Hogeman, C.H. van Zantwijk, P.D. Bezemer. Prognostic value of 5-nucleotidase in acute lymphoblastic leukemia with the common-ALL phenotype. Leuk Res 6: 1227 (1985).
4. R. Pieters, D.R. Huismans, A.H. Loonen, G.J. Peters, K. Hählen, A. van der Does-van den Berg, E.R. van Wering, A.J.P. Veerman. Relation of 5’-nucleotidase and Phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukemia. Leuk Res 16: 873 (1992).
5. M.M. Müller, M. Kraup, P. Chiba, H. Rumpold. Regulation of purine uptake in normal and neoplastic cells. Adv Enzyme Regul 21: 239 (1983).